I've charted the available Phase II trials data for Bisantrene (RAC) and PTX-200 (PTX).
Sources:
- Marty M, et al. Cancer Treat Rep. 1985;69:703-705. 2. Marty M, et al. Fourth International Symposium on
- Therapy of Acute Leukemia. Series Bisantrene: an anthracycline derivative active in ANLL: Phase 2 Study. Rome, Italy; 1987. Abstr. 598.
- Leblanc T, et al. Med Pediatr Oncol. 1994;22:119-124.
- Tosi P, et al. Haematologica. 1989;74:555-558.
- Bezwoda WR, Seymour L. Bone Marrow Transplant. 1989;4(suppl 3): 65.
- Spadea A, et al. Leuk Lymphoma 1993;9:217-220.
- https://www.asx.com.au/asxpdf/20191127/pdf/44c022j20vm3j9.pdf
![]()
- Forums
- ASX - By Stock
- RAC
- 1993: 5 of a total of 7 (72%) patients achieved total eradication of their cancer (R/R AML)
1993: 5 of a total of 7 (72%) patients achieved total eradication of their cancer (R/R AML), page-18
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.49 |
Change
-0.010(0.67%) |
Mkt cap ! $254.7M |
Open | High | Low | Value | Volume |
$1.50 | $1.51 | $1.49 | $73.29K | 48.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 107 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.51 | 1300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 6260 | 1.490 |
2 | 4908 | 1.485 |
3 | 1825 | 1.480 |
2 | 17265 | 1.475 |
1 | 950 | 1.470 |
Price($) | Vol. | No. |
---|---|---|
1.515 | 556 | 1 |
1.520 | 45 | 1 |
1.525 | 1 | 1 |
1.530 | 2355 | 1 |
1.575 | 6655 | 1 |
Last trade - 13.55pm 22/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online